Comparison between tazarotene 0.05 percent gel and adapalene 0.1 percent gel in acne patients.
Phase 3
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2024/06/069345
- Lead Sponsor
- Dr Sharwari Jaiswal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients irrespective of gender.
2)Patients with age >12 – 35 years.
3)Patients willing to participate.
4)Patients with acne grade: I, II, III.
Exclusion Criteria
1.History of hypersensitivity or allergic reaction to retinoids
2.Patients with a history of photosensitivity.
3.Females who are pregnant, lactating mothers and married women planning for pregnancy.
4.Patient with photo aggravated disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method